210 related articles for article (PubMed ID: 16343603)
21. The effect of off-pump coronary artery bypass grafting on platelet activation in patients on aspirin therapy until surgery day.
Suwalski G; Suwalski P; Filipiak KJ; Postuła M; Majstrak F; Opolski G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):365-9; discussion 369. PubMed ID: 18550381
[TBL] [Abstract][Full Text] [Related]
22. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
23. Platelet function predicts myocardial damage in patients with acute myocardial infarction.
Frossard M; Fuchs I; Leitner JM; Hsieh K; Vlcek M; Losert H; Domanovits H; Schreiber W; Laggner AN; Jilma B
Circulation; 2004 Sep; 110(11):1392-7. PubMed ID: 15313953
[TBL] [Abstract][Full Text] [Related]
24. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
Duygu H; Turkoglu C; Kirilmaz B; Turk U
J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
[TBL] [Abstract][Full Text] [Related]
25. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS.
Fuchs I; Frossard M; Spiel A; Riedmüller E; Laggner AN; Jilma B
J Thromb Haemost; 2006 Dec; 4(12):2547-52. PubMed ID: 17002662
[TBL] [Abstract][Full Text] [Related]
26. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
[TBL] [Abstract][Full Text] [Related]
27. The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting.
Foussas SG; Zairis MN; Patsourakos NG; Makrygiannis SS; Adamopoulou EN; Handanis SM; Prekates AA; Fakiolas CN; Pissimissis EG; Olympios CD; Argyrakis SK
Am Heart J; 2007 Oct; 154(4):676-81. PubMed ID: 17892990
[TBL] [Abstract][Full Text] [Related]
28. Factors responsible for "aspirin resistance" - can we identify them?
Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G
Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
[TBL] [Abstract][Full Text] [Related]
29. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
[TBL] [Abstract][Full Text] [Related]
30. The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation.
Siller-Matula JM; Haberl K; Prillinger K; Panzer S; Lang I; Jilma B
Thromb Res; 2009 Apr; 123(6):874-80. PubMed ID: 19135705
[TBL] [Abstract][Full Text] [Related]
31. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study.
Gurbel PA; Bliden KP; Guyer K; Cho PW; Zaman KA; Kreutz RP; Bassi AK; Tantry US
J Am Coll Cardiol; 2005 Nov; 46(10):1820-6. PubMed ID: 16286165
[TBL] [Abstract][Full Text] [Related]
32. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
33. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Carvajal J; Lehmann A; Lambert M; Bonnet JL; Alessi MC
J Am Coll Cardiol; 2006 Oct; 48(7):1339-45. PubMed ID: 17010792
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
35. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
[TBL] [Abstract][Full Text] [Related]
37. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
[TBL] [Abstract][Full Text] [Related]
38. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
39. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
40. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.
Geisler T; Kapp M; Göhring-Frischholz K; Daub K; Dösch C; Bigalke B; Langer H; Herdeg C; Gawaz M
Heart; 2008 Jun; 94(6):743-7. PubMed ID: 17567647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
